2011
DOI: 10.1155/2011/138929
|View full text |Cite
|
Sign up to set email alerts
|

Drug Nanoparticle Formulation Using Ascorbic Acid Derivatives

Abstract: Drug nanoparticle formulation using ascorbic acid derivatives and its therapeutic uses have recently been introduced. Hydrophilic ascorbic acid derivatives such as ascorbyl glycoside have been used not only as antioxidants but also as food and pharmaceutical excipients. In addition to drug solubilization, drug nanoparticle formation was observed using ascorbyl glycoside. Hydrophobic ascorbic acid derivatives such as ascorbyl mono- and di-n-alkyl fatty acid derivatives are used either as drugs or carrier compon… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
23
0

Year Published

2011
2011
2024
2024

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(26 citation statements)
references
References 32 publications
3
23
0
Order By: Relevance
“…We arrive at the reaction shown in ( The second-order rate constant (k) for reduction of Pt(IV) was calculated using (4) 4.39 Jk mol −1 (see Table 2). They are close to the reported value for similar systems [18,19,23]. The value of activation parameters is favorable for electron transfer reaction.…”
Section: Resultssupporting
confidence: 90%
See 1 more Smart Citation
“…We arrive at the reaction shown in ( The second-order rate constant (k) for reduction of Pt(IV) was calculated using (4) 4.39 Jk mol −1 (see Table 2). They are close to the reported value for similar systems [18,19,23]. The value of activation parameters is favorable for electron transfer reaction.…”
Section: Resultssupporting
confidence: 90%
“…L-ascorbic acid (H 2 ASc) has two acidic protons (pK 1 = 4.04 and pK 2 = 11.34) [18] and is a strong reducing agent (E 0 = 0.390 V NHE) in aqueous solutions. The electron transfer reaction between PtCl 6 2− and L-ascorbic acid was investigated by changing (L-ascorbic acid) in the range 0.05 to 0.3 mol dm −3 at [H + ] = 0.14 mol dm −3 and I = 0.5 mol dm −3 .…”
Section: Resultsmentioning
confidence: 99%
“…So excipient play major role with their contribution in above factors. Drug nanoparticle formulation using ascorbic acid derivatives (ascorbyl glycoside) used not only as antioxidant but also as carrier compound 37 .…”
Section: Conceptmentioning
confidence: 99%
“…The antioxidant potency of aspasome was much better than that of ascorbic acid [161, 162]. Thus, it can find applications as drug delivery system in disorders implicated with reactive oxygen species.…”
Section: Nonlipoidal Biocarriersmentioning
confidence: 99%